| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.07B | +3.4% | +36.8% |
| Cost of Revenue | $1.00B | +0.9% | -13.9% |
| Gross Profit | $1.07B | +5.9% | +206.2% |
| R&D Expense | $512.5M | -1.3% | +4.9% |
| SG&A Expense | $189.9M | -1.5% | -7.5% |
| Operating Income | $357.8M | +23.3% | +150.9% |
| Interest Expense | $47.9M | +2.4% | +5.0% |
| Income Tax | $314.1M | +707.5% | +523.3% |
| Net Income | $1.90B | +876.0% | +381.1% |
| EPS (Basic) | $2.22 | +865.2% | +384.6% |
| EPS (Diluted) | $2.20 | +900.0% | +382.1% |
| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.71B | +121.7% | +212.7% |
| Accounts Receivable | $1.55B | +6.5% | +55.0% |
| Inventory | $1.01B | -3.5% | +18.0% |
| Current Assets | $5.51B | +22.1% | +95.7% |
| Total Assets | $21.58B | +4.8% | +9.5% |
| Current Liabilities | $2.74B |
| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.38B | — | — |
| Capital Expenditures | $239.8M | — | — |
| Investing Cash Flow | $2.22B | — | — |
| Financing Cash Flow | -$1.83B | — | — |
| Free Cash Flow | $1.14B | — | — |
| +55.2% |
| Long-term Debt | $4.47B | +0.0% | +9.1% |
| Total Liabilities | $7.52B | +5.0% | +18.6% |
| Stockholders' Equity | $14.06B | +4.7% | +5.1% |